300725 Stock Overview
Provides chemistry products and services throughout the pharmaceutical research and development, and commercial production.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
PharmaBlock Sciences (Nanjing), Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥32.89 |
| 52 Week High | CN¥54.89 |
| 52 Week Low | CN¥23.25 |
| Beta | 0.52 |
| 1 Month Change | 9.71% |
| 3 Month Change | 15.36% |
| 1 Year Change | -39.01% |
| 3 Year Change | -77.51% |
| 5 Year Change | -29.88% |
| Change since IPO | 411.51% |
Recent News & Updates
Shareholder Returns
| 300725 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -5.7% | -2.0% | 0.02% |
| 1Y | -39.0% | -10.6% | -10.2% |
Return vs Industry: 300725 underperformed the CN Pharmaceuticals industry which returned -10.6% over the past year.
Return vs Market: 300725 underperformed the CN Market which returned -10.2% over the past year.
Price Volatility
| 300725 volatility | |
|---|---|
| 300725 Average Weekly Movement | 8.6% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in CN Market | 10.7% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300725's share price has been volatile over the past 3 months.
Volatility Over Time: 300725's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 2,455 | Minmin Yang | www.pharmablock.com |
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.
PharmaBlock Sciences (Nanjing), Inc. Fundamentals Summary
| 300725 fundamental statistics | |
|---|---|
| Market cap | CN¥6.54b |
| Earnings (TTM) | CN¥189.09m |
| Revenue (TTM) | CN¥1.72b |
34.6x
P/E Ratio3.8x
P/S RatioIs 300725 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300725 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.72b |
| Cost of Revenue | CN¥1.02b |
| Gross Profit | CN¥694.89m |
| Other Expenses | CN¥505.80m |
| Earnings | CN¥189.09m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.95 |
| Gross Margin | 40.42% |
| Net Profit Margin | 11.00% |
| Debt/Equity Ratio | 54.9% |
How did 300725 perform over the long term?
See historical performance and comparison